Refine by
Emergency Care Articles & Analysis
53 news found
Entegrion Announces CE Mark for Point of Care System for Blood Coagulation Monitoring. Regulatory clearance makes Entegrion’s innovative point of care diagnostic instrument for viscoelastic coagulation testing available to clinicians in Europe. ...
An interview with the lead author from The American Journal of Sports Medicine, Effects of the New York State Concussion Management and Awareness Act (“Lystedt Law”) on Concussion-Related Emergency Health Care Utilization Among Adolescents, 2005-2015 (here). ...
” Results from the analytical and clinical studies conclude that the Symphony IL-6 Test is an innovative technology for use in Emergency Department and Intensive Care Unit settings to identify COVID-19 patients at higher risk for severe disease, including the requirement for Invasive Mechanical Ventilation (IMV). ...
Their responses included: Reducing IV restarts Less trauma to patients by reducing restart-related needlesticks Preserving patient veins for subsequent procedures Maintaining IV access in emergency and critical care situations, and when transporting patients Lowered costs due to less waste of IV supplies. ...
Oxygen is usually supplied through an oxygen generator combined with a nasal cannula and can be used at the initial referral level of the primary health care or health care system. The coronavirus pandemic has exposed the oxygen gap faced by many low - and middle-income countries. ...
Zerhouni brings extensive experience in academia, government and industry as a leading authority on emerging trends and issues in medical care and biomedical research and development. ...
He also served as the Vice-President of Primary Care & Specialty Marketing for Eisai Pharmaceuticals. Thomas graduated with a degree in Engineering from the University of Wisconsin-Madison. ...
“This acquisition supports our strategy to build a portfolio of products that improves the standard of care for patients suffering from critical and rare conditions.” Xermelo will be commercially available from SERB outside the US and Japan starting in July 2022. ...
MatTek established its laboratories in Slovakia in 2009 to provide its European customers with local technical support and enhanced shipping capabilities to serve the pharmaceutical, chemical, cosmetic, and personal care industries in emerging markets. Production at the facility began in 2012 with EpiDerm, and has expanded to include EpiOcular, EpiIntestinal, ...
The AscencioDx represents a new generation of point-of-care molecular diagnostic testing that enables highly accurate results in about 30 minutes. ...
Andrew Barofsky, President and CEO of RevMedx, Inc., stated, “CE Mark on our XGAUZE product now makes our entire portfolio available to emergency responders and surgeons in the European Union and around the world. ...
ByRevMedx
Until now, patients needing routine or emergent care required transportation by medical charter flight hundreds of miles away to either Timmins or Kingston, ON. ...
Food and Drug Administration (“FDA”) cleared portable magnetic resonance imaging (“MRI”)TM device, Swoop®, is proud to announce that M Health Fairview is deploying a Swoop system in the emergency room (ER), intensive care unit (ICU) and post anesthesia environments at M Health Fairview University of Minnesota Medical Center. ...
About SERB and BTG Specialty Pharmaceuticals Together, SERB and BTG are a growing specialty pharmaceutical company and a dedicated ally to healthcare providers treating patients with critical conditions, focusing on emergency care and rare diseases. For over 30 years we have made treating these complex and life-threatening conditions possible, supporting ...
ECMO (ExtraCorporeal Membrane Oxygenation) centers who received ECMO plus CytoSorb therapy for life-threatening refractory respiratory failure under FDA EUA between April 2020 and April 2021.1 As highlighted in topline results that were previously presented at the 40th International Symposium on Intensive Care and Emergency Medicine (ISICEM 2021) conference in ...
BTG is a growing specialty pharmaceutical platform and a dedicated ally to healthcare providers treating patients with critical conditions, focusing on emergency care and rare diseases. For over 30 years we have made treating these complex and life-threatening conditions possible, supporting clinicians, healthcare systems and governments while offering hope to ...
About SERB and BTG Specialty Pharmaceuticals Together, SERB and BTG are a growing specialty pharmaceutical company and a dedicated ally to healthcare providers treating patients with critical conditions, focusing on emergency care and rare diseases. For over 30 years we have made treating these complex and life-threatening conditions possible, supporting ...
Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) in the near future. The initial EUA submission will claim effectiveness for administration by a licensed medical professional in a point-of-care setting, including physician offices, hospital emergency rooms, urgent care clinics, mobile testing sites, ...
About SERB and BTG Specialty Pharmaceuticals Together, SERB and BTG are a growing specialty pharmaceutical platform and a dedicated ally to healthcare providers treating patients with critical conditions, focusing on emergency care and rare diseases. For over 30 years we have made treating these complex and life-threatening conditions possible, supporting ...
(Imbed), a privately held biotech company emerging as a leader in advanced wound care, announced today the results of a prospective clinical evaluation of its next-generation wound Matrix, Microlyte® SURGICAL, in diabetic patients undergoing foot and ankle surgery who would ordinarily be at risk of a surgical site infection. Results will be published in the ...